Cargando…

CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro

Chimeric antigen receptor (CAR)-expressing macrophages (CAR-M) have a great potential to improve cancer therapy, as shown from several recent preclinical studies. However, unlike CAR-T cell therapy, which has been widely studied, the efficacy and limitations of CAR-M cells remain to be established....

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Maoxuan, Liu, Junchen, Liang, Ziwei, Dai, Kun, Gan, Jiangyu, Wang, Qi, Xu, Yang, Chen, Youhai H., Wan, Xiaochun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688246/ https://www.ncbi.nlm.nih.gov/pubmed/36429120 http://dx.doi.org/10.3390/cells11223692

Ejemplares similares

GPC3-targeted CAR-T cells secreting B7H3-targeted BiTE exhibit potent cytotoxicity activity against hepatocellular carcinoma cell in the in vitro assay
por: Cao, Guozheng, et al.
Publicado: (2022)

Synergistic effect of ibrutinib and CD19 CAR‐T cells on Raji cells in vivo and in vitro
por: Liu, Meijing, et al.
Publicado: (2020)

Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs
por: Anikeeva, Nadia, et al.
Publicado: (2021)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

Synergistic Effects of Zanubrutinib Combined With CD19 CAR-T Cells in Raji Cells in Vitro and in Vivo
por: Ye, Xiupeng, et al.
Publicado: (2022)

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2019)

New insights into CAR T cell-mediated killing of tumor cells
por: Espie, David, et al.
Publicado: (2022)

Clinical trials of CAR-T cells in China
por: Liu, Bingshan, et al.
Publicado: (2017)

CAR-NK Cells: From Natural Basis to Design for Kill
por: Khawar, Muhammad Babar, et al.
Publicado: (2021)

Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells
por: Pourzia, Alexandra L., et al.
Publicado: (2023)

Serpin B9 controls tumor cell killing by CAR T cells
por: Kimman, Thomas, et al.
Publicado: (2023)

Universal CARs, universal T cells, and universal CAR T cells
por: Zhao, Juanjuan, et al.
Publicado: (2018)

CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo
por: Golubovskaya, Vita, et al.
Publicado: (2023)

Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacy
por: McKenzie, Callum, et al.
Publicado: (2023)

CAR-T design: Elements and their synergistic function
por: Jayaraman, Jayapriya, et al.
Publicado: (2020)

Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionality
por: Schoutrop, Esther, et al.
Publicado: (2022)

Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy
por: Liu, Yanfen, et al.
Publicado: (2018)

Hypoxia Selectively Impairs CAR-T Cells In Vitro
por: Berahovich, Robert, et al.
Publicado: (2019)

Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia
por: Zhao, Juanjuan, et al.
Publicado: (2019)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021)

Anti-CD19 CAR T cells potently redirected to kill solid tumor cells
por: Ambrose, Christine, et al.
Publicado: (2021)

Engineering CAR-T cells
por: Zhang, Cheng, et al.
Publicado: (2017)

Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line
por: Wang, Lingyan, et al.
Publicado: (2022)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
por: Arjomandnejad, Motahareh, et al.
Publicado: (2022)

Making Potent CAR T Cells Using Genetic Engineering and Synergistic Agents
por: Park, Chi Hoon
Publicado: (2021)

An in vitro model of the macrophage-endothelial interface to characterize CAR T-cell induced cytokine storm
por: Rosen, Robert S., et al.
Publicado: (2023)

Synergistic killing effects of PD-L1-CAR T cells and colorectal cancer stem cell-dendritic cell vaccine-sensitized T cells in ALDH1-positive colorectal cancer stem cells
por: Liu, Liu, et al.
Publicado: (2021)

Editorial: The mechanism and novel strategies of overcoming resistance of hematological malignancies to CAR-T cell killing
por: Zhang, Tingting, et al.
Publicado: (2022)

Nanobody Based Dual Specific CARs
por: De Munter, Stijn, et al.
Publicado: (2018)

CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells
por: Strohl, William R., et al.
Publicado: (2019)

Tubercular Infection in Street Cars
por: Bissell, William G.
Publicado: (1895)

CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
por: Kim, Gloria B., et al.
Publicado: (2019)

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2023)

CAR T-Cell Targeting of Macrophage Colony-Stimulating Factor Receptor
por: Achkova, Daniela Yordanova, et al.
Publicado: (2022)

CAR-T Cell Therapy
por: Ahmad, Aamir
Publicado: (2020)

Anterior chamber infiltration of CAR T-cells
por: Jacoby, Elad, et al.
Publicado: (2021)

CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy
por: Sacchetti, Benedetto, et al.
Publicado: (2019)

Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells
por: Koristka, Stefanie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rfbmcc88gsk02u8gqmmrvjhk0j